Industry Research Reports
Home > Reports > Chemical & Material > Glimepiride API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Glimepiride API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Industry: Chemical & Material
Published Date: 2025-02-15
Pages: 116 Pages
Report ld: 3959944
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
The global market for Glimepiride API was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Glimepiride is a long-acting, third-generation sulfonylurea with hypoglycemic activity. Compared to other generations of sulfonylurea compounds, glimepiride is very potent and has a longer duration of action. This agent is metabolized by CYP2C9 and shows peroxisome proliferator-activated receptor gamma (PPARgamma) agonistic activity.
North American market for Glimepiride API was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Glimepiride API was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Glimepiride API was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global key companies of Glimepiride API include Dr. Reddy’s Laboratories Ltd., SANOFI Active Ingredient Solutions, Dishman Carbogen Amcis, Glenmark Pharmaceuticals, Sharon Bio-Medicine Limited, Supra Chemicals, Rakshit Drugs, Estechpharma Co., Ltd., Nishchem International Pvt. Ltd, Nexchem Pharmaceutical Co, ltd, etc. In 2024, the global five largest players hold a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Glimepiride API, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Glimepiride API by region & country, by Type, and by Application.
The Glimepiride API market size, estimations, and forecasts are provided in terms of sales volume (Ton) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Glimepiride API.
MARKET SEGMENTATION
By Company
- Dr. Reddy’s Laboratories Ltd.
- SANOFI Active Ingredient Solutions
- Dishman Carbogen Amcis
- Glenmark Pharmaceuticals
- Sharon Bio-Medicine Limited
- Supra Chemicals
- Rakshit Drugs
- Estechpharma Co., Ltd.
- Nishchem International Pvt. Ltd
- Nexchem Pharmaceutical Co, ltd
- Maps Laboratories Private Limited
- CAD Middle East Pharmaceutical
- Hanways Chempharm Co., Limited
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Purity≥98%
- Purity<98%
Segment by Application
- Glimepiride Tablets
- Others
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Glimepiride API Product Introduction
1.2 Global Glimepiride API Market Size Forecast
1.2.1 Global Glimepiride API Sales Value (2020-2031)
1.2.2 Global Glimepiride API Sales Volume (2020-2031)
1.2.3 Global Glimepiride API Sales Price (2020-2031)
1.3 Glimepiride API Market Trends & Drivers
1.3.1 Glimepiride API Industry Trends
1.3.2 Glimepiride API Market Drivers & Opportunity
1.3.3 Glimepiride API Market Challenges
1.3.4 Glimepiride API Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Glimepiride API Players Revenue Ranking (2024)
2.2 Global Glimepiride API Revenue by Company (2020-2025)
2.3 Global Glimepiride API Players Sales Volume Ranking (2024)
2.4 Global Glimepiride API Sales Volume by Company Players (2020-2025)
2.5 Global Glimepiride API Average Price by Company (2020-2025)
2.6 Key Manufacturers Glimepiride API Manufacturing Base and Headquarters
2.7 Key Manufacturers Glimepiride API Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Glimepiride API
2.9 Glimepiride API Market Competitive Analysis
2.9.1 Glimepiride API Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Glimepiride API Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Glimepiride API as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Purity≥98%
3.1.2 Purity
TABLE OF FIGURES
List of Tables
Table 1. Glimepiride API Market Trends
Table 2. Glimepiride API Market Drivers & Opportunity
Table 3. Glimepiride API Market Challenges
Table 4. Glimepiride API Market Restraints
Table 5. Global Glimepiride API Revenue by Company (2020-2025) & (US$ Million)
Table 6. Global Glimepiride API Revenue Market Share by Company (2020-2025)
Table 7. Global Glimepiride API Sales Volume by Company (2020-2025) & (Ton)
Table 8. Global Glimepiride API Sales Volume Market Share by Company (2020-2025)
Table 9. Global Market Glimepiride API Price by Company (2020-2025) & (US$/Ton)
Table 10. Key Manufacturers Glimepiride API Manufacturing Base and Headquarters
Table 11. Key Manufacturers Glimepiride API Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Glimepiride API
Table 13. Global Glimepiride API Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Glimepiride API as of 2024)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Glimepiride API Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
Table 17. Global Glimepiride API Sales Value by Type (2020-2025) & (US$ Million)
Table 18. Global Glimepiride API Sales Value by Type (2026-2031) & (US$ Million)
Table 19. Global Glimepiride API Sales Market Share in Value by Type (2020-2025)
Table 20. Global Glimepiride API Sales Market Share in Value by Type (2026-2031)
Table 21. Global Glimepiride API Sales Volume by Type: 2020 VS 2024 VS 2031 (Ton)
Table 22. Global Glimepiride API Sales Volume by Type (2020-2025) & (Ton)
Table 23. Global Glimepiride API Sales Volume by Type (2026-2031) & (Ton)
Table 24. Global Glimepiride API Sales Market Share in Volume by Type (2020-2025)
Table 25. Global Glimepiride API Sales Market Share in Volume by Type (2026-2031)
Table 26. Global Glimepiride API Price by Type (2020-2025) & (US$/Ton)
Table 27. Global Glimepiride API Price by Type (2026-2031) & (US$/Ton)
Table 28. Global Glimepiride API Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
Table 29. Global Glimepiride API Sales Value by Application (2020-2025) & (US$ Million)
Table 30. Global Glimepiride API Sales Value by Application (2026-2031) & (US$ Million)
Table 31. Global Glimepiride API Sales Market Share in Value by Application (2020-2025)
Table 32. Global Glimepiride API Sales Market Share in Value by Application (2026-2031)
Table 33. Global Glimepiride API Sales Volume by Application: 2020 VS 2024 VS 2031 (Ton)
Table 34. Global Glimepiride API Sales Volume by Application (2020-2025) & (Ton)
Table 35. Global Glimepiride API Sales Volume by Application (2026-2031) & (Ton)
Table 36. Global Glimepiride API Sales Market Share in Volume by Application (2020-2025)
Table 37. Global Glimepiride API Sales Market Share in Volume by Application (2026-2031)
Table 38. Global Glimepiride API Price by Application (2020-2025) & (US$/Ton)
Table 39. Global Glimepiride API Price by Application (2026-2031) & (US$/Ton)
Table 40. Global Glimepiride API Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
Table 41. Global Glimepiride API Sales Value by Region (2020-2025) & (US$ Million)
Table 42. Global Glimepiride API Sales Value by Region (2026-2031) & (US$ Million)
Table 43. Global Glimepiride API Sales Value by Region (2020-2025) & (%)
Table 44. Global Glimepiride API Sales Value by Region (2026-2031) & (%)
Table 45. Global Glimepiride API Sales Volume by Region (Ton): 2020 VS 2024 VS 2031
Table 46. Global Glimepiride API Sales Volume by Region (2020-2025) & (Ton)
Table 47. Global Glimepiride API Sales Volume by Region (2026-2031) & (Ton)
Table 48. Global Glimepiride API Sales Volume by Region (2020-2025) & (%)
Table 49. Global Glimepiride API Sales Volume by Region (2026-2031) & (%)
Table 50. Global Glimepiride API Average Price by Region (2020-2025) & (US$/Ton)
Table 51. Global Glimepiride API Average Price by Region (2026-2031) & (US$/Ton)
Table 52. Key Countries/Regions Glimepiride API Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
Table 53. Key Countries/Regions Glimepiride API Sales Value, (2020-2025) & (US$ Million)
Table 54. Key Countries/Regions Glimepiride API Sales Value, (2026-2031) & (US$ Million)
Table 55. Key Countries/Regions Glimepiride API Sales Volume, (2020-2025) & (Ton)
Table 56. Key Countries/Regions Glimepiride API Sales Volume, (2026-2031) & (Ton)
Table 57. Dr. Reddy’s Laboratories Ltd. Company Information
Table 58. Dr. Reddy’s Laboratories Ltd. Introduction and Business Overview
Table 59. Dr. Reddy’s Laboratories Ltd. Glimepiride API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 60. Dr. Reddy’s Laboratories Ltd. Glimepiride API Product Offerings
Table 61. Dr. Reddy’s Laboratories Ltd. Recent Development
Table 62. SANOFI Active Ingredient Solutions Company Information
Table 63. SANOFI Active Ingredient Solutions Introduction and Business Overview
Table 64. SANOFI Active Ingredient Solutions Glimepiride API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 65. SANOFI Active Ingredient Solutions Glimepiride API Product Offerings
Table 66. SANOFI Active Ingredient Solutions Recent Development
Table 67. Dishman Carbogen Amcis Company Information
Table 68. Dishman Carbogen Amcis Introduction and Business Overview
Table 69. Dishman Carbogen Amcis Glimepiride API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 70. Dishman Carbogen Amcis Glimepiride API Product Offerings
Table 71. Dishman Carbogen Amcis Recent Development
Table 72. Glenmark Pharmaceuticals Company Information
Table 73. Glenmark Pharmaceuticals Introduction and Business Overview
Table 74. Glenmark Pharmaceuticals Glimepiride API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 75. Glenmark Pharmaceuticals Glimepiride API Product Offerings
Table 76. Glenmark Pharmaceuticals Recent Development
Table 77. Sharon Bio-Medicine Limited Company Information
Table 78. Sharon Bio-Medicine Limited Introduction and Business Overview
Table 79. Sharon Bio-Medicine Limited Glimepiride API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 80. Sharon Bio-Medicine Limited Glimepiride API Product Offerings
Table 81. Sharon Bio-Medicine Limited Recent Development
Table 82. Supra Chemicals Company Information
Table 83. Supra Chemicals Introduction and Business Overview
Table 84. Supra Chemicals Glimepiride API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 85. Supra Chemicals Glimepiride API Product Offerings
Table 86. Supra Chemicals Recent Development
Table 87. Rakshit Drugs Company Information
Table 88. Rakshit Drugs Introduction and Business Overview
Table 89. Rakshit Drugs Glimepiride API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 90. Rakshit Drugs Glimepiride API Product Offerings
Table 91. Rakshit Drugs Recent Development
Table 92. Estechpharma Co., Ltd. Company Information
Table 93. Estechpharma Co., Ltd. Introduction and Business Overview
Table 94. Estechpharma Co., Ltd. Glimepiride API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 95. Estechpharma Co., Ltd. Glimepiride API Product Offerings
Table 96. Estechpharma Co., Ltd. Recent Development
Table 97. Nishchem International Pvt. Ltd Company Information
Table 98. Nishchem International Pvt. Ltd Introduction and Business Overview
Table 99. Nishchem International Pvt. Ltd Glimepiride API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 100. Nishchem International Pvt. Ltd Glimepiride API Product Offerings
Table 101. Nishchem International Pvt. Ltd Recent Development
Table 102. Nexchem Pharmaceutical Co, ltd Company Information
Table 103. Nexchem Pharmaceutical Co, ltd Introduction and Business Overview
Table 104. Nexchem Pharmaceutical Co, ltd Glimepiride API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 105. Nexchem Pharmaceutical Co, ltd Glimepiride API Product Offerings
Table 106. Nexchem Pharmaceutical Co, ltd Recent Development
Table 107. Maps Laboratories Private Limited Company Information
Table 108. Maps Laboratories Private Limited Introduction and Business Overview
Table 109. Maps Laboratories Private Limited Glimepiride API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 110. Maps Laboratories Private Limited Glimepiride API Product Offerings
Table 111. Maps Laboratories Private Limited Recent Development
Table 112. CAD Middle East Pharmaceutical Company Information
Table 113. CAD Middle East Pharmaceutical Introduction and Business Overview
Table 114. CAD Middle East Pharmaceutical Glimepiride API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 115. CAD Middle East Pharmaceutical Glimepiride API Product Offerings
Table 116. CAD Middle East Pharmaceutical Recent Development
Table 117. Hanways Chempharm Co., Limited Company Information
Table 118. Hanways Chempharm Co., Limited Introduction and Business Overview
Table 119. Hanways Chempharm Co., Limited Glimepiride API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 120. Hanways Chempharm Co., Limited Glimepiride API Product Offerings
Table 121. Hanways Chempharm Co., Limited Recent Development
Table 122. Key Raw Materials Lists
Table 123. Raw Materials Key Suppliers Lists
Table 124. Glimepiride API Downstream Customers
Table 125. Glimepiride API Distributors List
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. Glimepiride API Product Picture
Figure 2. Global Glimepiride API Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Global Glimepiride API Sales Value (2020-2031) & (US$ Million)
Figure 4. Global Glimepiride API Sales Volume (2020-2031) & (Ton)
Figure 5. Global Glimepiride API Sales Price (2020-2031) & (US$/Ton)
Figure 6. Glimepiride API Report Years Considered
Figure 7. Global Glimepiride API Players Revenue Ranking (2024) & (US$ Million)
Figure 8. Global Glimepiride API Players Sales Volume Ranking (2024) & (Ton)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Glimepiride API Revenue in 2024
Figure 10. Glimepiride API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 11. Purity≥98% Picture
Figure 12. Purity
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Glimepiride API market?
The top companies in the global Glimepiride API market are Dr. Reddy’s Laboratories Ltd.、SANOFI Active Ingredient Solutions、Dishman Carbogen Amcis.
Related Reports
Glimepiride API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Glimepiride API was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-07-14
Pages: 142
USD 3950.00
(Single User License)
Global Glimepiride API Market Research Report 2026
The global Glimepiride API market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-21
Pages: 145
USD 2900.00
(Single User License)
Global Glimepiride API Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Glimepiride API market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-22
Pages: 162
USD 4900.00
(Single User License)
Global Glimepiride API Market Research Report 2025
The global market for Glimepiride API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-15
Pages: 102
USD 2900.00
(Single User License)
Global Glimepiride API Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Glimepiride API market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-15
Pages: 91
USD 4250.00
(Single User License)
Global Glimepiride API Market Insights, Forecast to 2030
Glimepiride is a long-acting, third-generation sulfonylurea with hypoglycemic activity. Compared to other generations of sulfonylurea compounds, glimepiride is very potent and has a longer duration of action. This agent is metabolized by CYP2C9 and shows peroxisome proliferator-activated receptor gamma (PPARgamma) agonistic activity.
Published Date: 2024-04-15
Pages: 114
USD 4900.00
(Single User License)
Glimepiride API - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Glimepiride is a long-acting, third-generation sulfonylurea with hypoglycemic activity. Compared to other generations of sulfonylurea compounds, glimepiride is very potent and has a longer duration of action. This agent is metabolized by CYP2C9 and shows peroxisome proliferator-activated receptor gamma (PPARgamma) agonistic activity.
Published Date: 2024-02-23
Pages: 127
USD 3950.00
(Single User License)
Global Glimepiride API Market Research Report 2024
Glimepiride is a long-acting, third-generation sulfonylurea with hypoglycemic activity. Compared to other generations of sulfonylurea compounds, glimepiride is very potent and has a longer duration of action. This agent is metabolized by CYP2C9 and shows peroxisome proliferator-activated receptor gamma (PPARgamma) agonistic activity.
Published Date: 2024-01-10
Pages: 103
USD 2900.00
(Single User License)
Glimepiride API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Glimepiride API was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-07-14
Pages: 142
USD 3950.00 (Single User License)Global Glimepiride API Market Research Report 2026
The global Glimepiride API market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-21
Pages: 145
USD 2900.00 (Single User License)Global Glimepiride API Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Glimepiride API market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-22
Pages: 162
USD 4900.00 (Single User License)Global Glimepiride API Market Research Report 2025
The global market for Glimepiride API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-15
Pages: 102
USD 2900.00 (Single User License)Global Glimepiride API Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Glimepiride API market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-15
Pages: 91
USD 4250.00 (Single User License)Global Glimepiride API Market Insights, Forecast to 2030
Glimepiride is a long-acting, third-generation sulfonylurea with hypoglycemic activity. Compared to other generations of sulfonylurea compounds, glimepiride is very potent and has a longer duration of action. This agent is metabolized by CYP2C9 and shows peroxisome proliferator-activated receptor gamma (PPARgamma) agonistic activity.
Published: 2024-04-15
Pages: 114
USD 4900.00 (Single User License)Glimepiride API - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Glimepiride is a long-acting, third-generation sulfonylurea with hypoglycemic activity. Compared to other generations of sulfonylurea compounds, glimepiride is very potent and has a longer duration of action. This agent is metabolized by CYP2C9 and shows peroxisome proliferator-activated receptor gamma (PPARgamma) agonistic activity.
Published: 2024-02-23
Pages: 127
USD 3950.00 (Single User License)Global Glimepiride API Market Research Report 2024
Glimepiride is a long-acting, third-generation sulfonylurea with hypoglycemic activity. Compared to other generations of sulfonylurea compounds, glimepiride is very potent and has a longer duration of action. This agent is metabolized by CYP2C9 and shows peroxisome proliferator-activated receptor gamma (PPARgamma) agonistic activity.
Published: 2024-01-10
Pages: 103
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 3950.00
USD 5925.00
USD 7900.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now